| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| PS-5505 |
|
2409964-23-2 |
詳細(xì)
|
| PS-5505 |
|
2409963-83-1 |
詳細(xì)
|
| (S)-Methyl 6-Hydroxy-2,3-dihydrobenzofuran-3-ylacetate |
6-羥基-2,3-二氫苯丙呋喃-3-基乙酸-(S)-甲酯 |
1000414-38-9 |
詳細(xì)
|
| 4-Fluoro-3-hydroxyphenylboronic acid |
4-氟-3-羥基苯硼酸 |
913835-74-2 |
詳細(xì)
|
| tert-butyl 2,7-diazaspiro[3.5]nonane-7-carboxylate hydrochloride |
2,7-二氮雜螺[3.5]壬烷-7-甲酸叔丁酯鹽酸鹽 |
1023301-84-9 |
詳細(xì)
|
| 4,6-Dichloro-1H-pyrazolo[4,3-c]pyridine |
4,6-二氯-1H-吡唑并[4,3-c]吡啶 |
1256794-28-1 |
詳細(xì)
|
| (R)-1-Boc-2-azetidinemethanol |
(R)-1-(叔丁氧羰基)-2-吖丁啶甲醇 |
161511-90-6 |
詳細(xì)
|
| 3-Methyl-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenol |
4-羥基-2-甲基苯硼酸頻呢醇酯 |
946427-03-8 |
詳細(xì)
|
| 3-AMino-2,2-difluoropropanoic acid hydrochlorid |
3-氨基-2,2-二氟丙酸鹽酸鹽 |
1159825-06-5 |
詳細(xì)
|
| 2,4-dichloro-6-methoxypyrimidine |
2,4-二氯-6-甲氧基嘧啶 |
43212-41-5 |
詳細(xì)
|
| 7-Bromo-4-fluoro-1-indanone |
7-溴-4-氟-2,3-二氫-1H-茚-1-酮 |
881189-73-7 |
詳細(xì)
|
| N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)acetamide |
2-乙酰氨基吡啶-4-硼酸頻那醇酯 |
1220220-21-2 |
詳細(xì)
|
| 6-benzyl 1-ethyl 6-azaspiro[2.5]octane-1,6-dicarboxylate |
6-芐基-1-乙基6-氮雜螺[2.5]辛烷-1,6-二羧酸酯 |
147610-84-2 |
詳細(xì)
|
| Ethyl 3-Amino-2,2-difluoropropanoate Hydrochloride |
2,2-二氟-3-氨基丙酸乙酯鹽酸鹽 |
1263284-04-3 |
詳細(xì)
|
| 2,3,6-Trichloro-4-(trifluoromethyl)pyridine |
2,3,6-三氯-4-三氟甲基吡啶 |
81565-20-0 |
詳細(xì)
|
| 3-cyclopropylpyrrolidine |
3-環(huán)丙基-吡咯烷 |
1250004-31-9 |
詳細(xì)
|
| tert-Butyl 5-bromoisoindoline-2-carboxylate |
5-溴異吲哚啉-2-碳酸叔丁酯 |
201940-08-1 |
詳細(xì)
|
| 4-Bromo-2-methylbenzenemethanamine |
4-溴-2-甲基苯甲胺 |
376646-62-7 |
詳細(xì)
|
| (S)-1-Cyclopropylethylamine |
(S)-1-環(huán)丙基乙胺 |
195604-39-8 |
詳細(xì)
|
| Tranexamic acid |
氨甲環(huán)酸 |
1197-18-8 |
詳細(xì)
|
| Spastazoline |
|
2351882-11-4 |
詳細(xì)
|
| VU6012962 |
|
|
詳細(xì)
|
| RK-287107 |
RK-287107 |
2171386-10-8 |
詳細(xì)
|
| AWZ1066S |
|
2239272-16-1 |
詳細(xì)
|
| GSK-547 |
|
2226735-55-1 |
詳細(xì)
|
| FT-113 |
|
|
詳細(xì)
|
| Lesinurad Impurity Z |
雷西納德雜質(zhì)Z |
|
詳細(xì)
|
| Lesinurad Impurity B |
雷西納德雜質(zhì)B |
1533519-93-5 |
詳細(xì)
|
| Lesinurad Impurity 3 |
雷西納德雜質(zhì)3 |
1384208-36-9 |
詳細(xì)
|
| Lixivaptan |
|
168079-32-1 |
詳細(xì)
|
| GSK-2894631A |
|
2101626-26-8 |
詳細(xì)
|
| KL-1333 |
|
1800405-30-4 |
詳細(xì)
|
| NVS-ZP7-4 |
|
|
詳細(xì)
|
|
鹽酸芐替米特 |
5633-14-7 |
詳細(xì)
|
| AER-271 |
|
634913-39-6 |
詳細(xì)
|
| DSP-2230 |
|
1233231-30-5 |
詳細(xì)
|
| vanin-1 inhibitor |
|
2173134-00-2 |
詳細(xì)
|
| ACH-4471 |
|
1903768-17-1 |
詳細(xì)
|
| nAChR agonist1 |
|
1394371-75-5 |
詳細(xì)
|
| RBN-2397 |
|
2381037-82-5 |
詳細(xì)
|
| AZD-7648 |
|
2230820-11-6 |
詳細(xì)
|
| LUT-014 |
LUT-014 |
2274819-46-2 |
詳細(xì)
|
| Tavapadon |
|
1643489-24-0 |
詳細(xì)
|
| suvn-911 |
|
2414674-71-6 |
詳細(xì)
|
| SR-4835 |
|
2387704-62-1 |
詳細(xì)
|
| ε-Pyrrole-lysine |
ε-吡咯賴氨酸 |
74509-14-1 |
詳細(xì)
|
| Ferric Carboxymaltos |
羧基麥芽糖鐵 |
9007-72-1 |
詳細(xì)
|
| PXL007 |
|
1192171-69-9 |
詳細(xì)
|
| (1R,2R)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-2-methyl-8-azaspiro[4.5]decan-1-amine |
|
1801765-04-7 |
詳細(xì)
|
| MDR652 |
|
1933528-96-1 |
詳細(xì)
|
| PK68 |
|
2173556-69-7 |
詳細(xì)
|
| CC-90001 |
|
1403859-14-2 |
詳細(xì)
|
| LTT-462 |
|
1715025-32-3 |
詳細(xì)
|
| Seltorexant |
|
1293281-49-8 |
詳細(xì)
|
| Licogliflozin |
|
1291094-73-9 |
詳細(xì)
|
| PF-06882961 |
|
2230198-02-2 |
詳細(xì)
|
| ACH-000143 |
|
2225836-30-4 |
詳細(xì)
|
| (S)-beta-(4-Fluorophenyl)alaninol |
|
228422-49-9 |
詳細(xì)
|
|
|
119327-17-2 |
詳細(xì)
|
| Nifeviroc |
|
934740-33-7 |
詳細(xì)
|
| SHR0302 |
|
1445987-21-2 |
詳細(xì)
|
|
卡培他濱 |
154361-50-9 |
詳細(xì)
|
| Imatinib |
伊馬替尼 |
152459-95-5 |
詳細(xì)
|
| 4-ethyl-2-fluoroaniline |
4-乙基-2-氟苯胺 |
821791-69-9 |
詳細(xì)
|
| 4-(Hydroxymethyl)cyclohexan-1-one |
4-(羥甲基)環(huán)己酮 |
38580-68-6 |
詳細(xì)
|
| Methyl 4-Amino-3-bromo-5-fluorobenzoate |
|
1123171-91-4 |
詳細(xì)
|
| (2S)-3-[(tert-butoxy)carbonyl]-1,3-thiazolidine-2-carboxylic acid |
(2S)-3-[(叔-丁氧基)羰基]-1,3-噻唑烷-2-羧酸 |
891192-95-3 |
詳細(xì)
|
| PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID |
吡唑[1,5-A]嘧啶-3-羧酸 |
25940-35-6 |
詳細(xì)
|
| AB680 |
|
2105904-82-1 |
詳細(xì)
|
| IACS-13909 |
|
2160546-07-4 |
詳細(xì)
|
| AZD-5305 |
|
2589531-76-8 |
詳細(xì)
|
| CTX-3648 |
|
2569009-58-9 |
詳細(xì)
|
| AB-928 |
|
2239273-34-6 |
詳細(xì)
|
| AT-007 |
|
2170729-29-8 |
詳細(xì)
|
| GS-4361 |
|
2291164-02-6 |
詳細(xì)
|
| Ketohexokinase inhibitor 1 |
|
2102501-84-6 |
詳細(xì)
|
| CC-90011 |
|
2097523-60-7 |
詳細(xì)
|
| N-Desmethyl Netupitant |
|
290296-72-9 |
詳細(xì)
|
| Monohydroxy Netupitant |
|
910808-12-7 |
詳細(xì)
|
| Favipiravir(T-705) |
法匹拉韋 |
259793-96-9 |
詳細(xì)
|
| LML-134 |
|
1542135-76-1 |
詳細(xì)
|
| EC-5026 |
|
1809885-32-2 |
詳細(xì)
|
| BMS-615 |
|
2180127-82-4 |
詳細(xì)
|
| VU6015929 |
|
|
詳細(xì)
|
| GSK8612 |
|
|
詳細(xì)
|
| BMS-986242 |
|
1923844-48-7 |
詳細(xì)
|
| UMB298 |
|
2266569-73-5 |
詳細(xì)
|
| Sisunatovir HCl |
|
1903763-83-6 |
詳細(xì)
|
| CA-4948 |
|
1801344-14-8 |
詳細(xì)
|
| EST73502 |
|
2307458-82-6 |
詳細(xì)
|
| AHR antagonist 3 |
|
2242464-44-2 |
詳細(xì)
|
| NTP42 |
|
2055599-51-2 |
詳細(xì)
|
| GSK3145095 |
|
1622849-43-7 |
詳細(xì)
|
| NCC007 |
NCC007 |
|
詳細(xì)
|
| Ethyl 5,5,5-trifluoro-2,4-dioxopentanoate |
5,5,5-三氟-2,4-二氧代戊酸乙酯 |
893643-18-0 |
詳細(xì)
|
| 2-bromo-4-chloro-1-(difluoromethoxy)benzene |
2-溴-4-氯-1-(二氟甲氧基)苯 |
1214348-81-8 |
詳細(xì)
|
| XL-092 |
|
2367004-54-2 |
詳細(xì)
|
| BAY-2335218 |
CPD3504 |
2162982-11-6 |
詳細(xì)
|
| (2,6-Dichloro-pyrimidin-4-yl)-dimethyl-amine |
|
117077-93-7 |
詳細(xì)
|
| DS-1971a |
|
1450595-86-4 |
詳細(xì)
|